BTIG Keeps Their Buy Rating on DraftKings (DKNG)
In a report released today, Clark Lampen from BTIG maintained a Buy rating on DraftKings (DKNG – Research Report), with a price target of ...
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will host investor meetings at the BTIG MedTech, ...
Investing14h
BTIG senkt IQVIA-Aktienrating auf neutral angesichts Sektorengegenwind
Am Montag passte BTIG-Analyst David Larsen die Einschätzung der Firma zu IQVIA Holdings (NYSE: IQV) an und stufte sie von Kaufen auf Neutral herab. Das Unternehmen mit einer Marktkapitalisierung von 3 ...
Iqvia downgraded to Neutral from Buy at BTIG
BTIG analyst David Larsen downgraded Iqvia (IQV) to Neutral from Buy without a price target The firm says clinical research organization ...
IDEXX stock price target raised to $530 at BTIG
BTIG analyst Mark Massaro announced an increased price target for IDEXX Laboratories (NASDAQ:IDXX), raising it from $500 to $530, while maintaining a Buy rating on the stock. The revision follows ...
TMCnet10h
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
BTIG is a leading global financial services firm specializing in investment banking, institutional trading, research, and ...
HOPE Therapeuticstm, Inc. And Nrx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG As Financial Advisor
The Company has recently announced execution of an agreement for $27 million in funding for HOPE <a target=_blank href= ...
BTIG cuts IQVIA stock rating to neutral amid sector headwinds
BTIG analyst David Larsen adjusted the firm's stance on IQVIA Holdings (NYSE:IQV), moving from a Buy rating to Neutral. The $36.5 billion market cap company, currently trading near its 52-week low at ...
Rithm Capital Affiliated SPAC Files for $200M IPO
Blank check company Rithm Acquisition, which is affiliated with Rithm Capital, filed for a $200 million initial public offering on Monday. The company said Michael Nierenberg, its chairman and chief ...
Tech’s drawdown could create a new leadership potential – BTIG’s Krinsky
Market technician Jonathan Krinsky analyzes the shift in market leadership from technology to healthcare amid recent ...
Investing5d
BTIG maintains Neutral on NVR stock, trims EPS estimates
On Wednesday, BTIG analyst Carl Reichardt Jr. maintained a Neutral rating on shares of NVR Inc . (NYSE:NVR), while slightly lowering earnings per share (EPS) estimates for the upcoming years.
Yahoo Finance6d
Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 28, 2025--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the BTIG Annual ...